A drug used to date to treat type II diabetes is actually effective in losing weight and does not produce significant side effects. In addition to surgery, there are currently no other treatments that meet these two conditions; existing medications are ineffective and have side effects that greatly limit their use.
The drug, called semaglutide, has been tested in an international clinical session at doses higher than the treatment of diabetes. 2,000 people from sixteen countries took a weekly dose of semi-ligant or placebo by injection for 68 weeks. At the same time, they changed their lifestyle in terms of diet and exercise. Occupants lost 15% by weight and placebos 2.4%. In few cases it caused nausea, diarrhea and scratches, which in most cases disappeared in the short term. These results have been published in the journal The New England Journal of Medicine.
Semaglutine mimics the GLP1 hormone that flows when our body takes a lot of food, thus eliminating hunger. Some of the people who participated in the session said that after the session ended, they began to feel hungry and have gained weight. In fact, a clinical session of 5 years ago has been launched to check whether it is possible to maintain long-term weight loss and whether in that dose and long-term there may be other side effects.